OP 1.7 – 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir

• M. Pardons,
• B. Cole,
• L. Lambrechts,
• S. Rutsaert,
• Y. Noppe,
• J. Vega,
• E. Nijs,
• E. Van Gulck,
• D. Boden,
• L. Vandekerckhove

Affiliations

M. Pardons

Hiv Cure Research Center, Department of Internal Medicine And Pediatrics, Ghent University, Ghent, Belgium

B. Cole

Hiv Cure Research Center, Department of Internal Medicine And Pediatrics, Ghent University, Ghent, Belgium

L. Lambrechts

Hiv Cure Research Center, Department of Internal Medicine And Pediatrics, Ghent University, Ghent, Belgium

S. Rutsaert

Hiv Cure Research Center, Department of Internal Medicine And Pediatrics, Ghent University, Ghent, Belgium

Y. Noppe

Hiv Cure Research Center, Department of Internal Medicine And Pediatrics, Ghent University, Ghent, Belgium

J. Vega

Arcturus Therapeutics, Science Center Drive - San Diego, USA

E. Nijs

Janssen Infectious Diseases And Diagnostics, Johnson And Johnson, Beerse, Belgium

E. Van Gulck

Janssen Infectious Diseases And Diagnostics, Johnson And Johnson, Beerse, Belgium

D. Boden

Janssen Biopharma, Johnson And Johnson, South San Francisco, USA

L. Vandekerckhove

Hiv Cure Research Center, Department of Internal Medicine And Pediatrics, Ghent University, Ghent, Belgium